HMGB1, RAGE
K |
K |
||
| (Eine dazwischenliegende Version von einem Benutzer wird nicht angezeigt) | |||
| Zeile 1: | Zeile 1: | ||
{{up|PHA Biologicals}} | {{up|PHA Biologicals}} | ||
| − | + | ---- | |
| + | ich habe seinerzeit den dewiki über hmgb1 erstmalig geschrieben https://de.wikipedia.org/w/index.php?title=High-Mobility-Group-Protein_B1&oldid=44046975 , aber wie man weiß, wikipedia kloppt die autoren tot und seit 2009 mache ich andere medizinische Webinhalte. | ||
| + | ---- | ||
{{tp|p=32375153|t=2020. HMGB1: A Possible Crucial Therapeutic Target for COVID-19?|pdf=|usr=}} | {{tp|p=32375153|t=2020. HMGB1: A Possible Crucial Therapeutic Target for COVID-19?|pdf=|usr=}} | ||
{{tp|p=23607598|t=2013. (x)Involvement of high mobility group box 1 and the therapeutic effect of recombinant thrombomodulin in a mouse model of severe acute respiratory distress syndrome |pdf=|usr=}} | {{tp|p=23607598|t=2013. (x)Involvement of high mobility group box 1 and the therapeutic effect of recombinant thrombomodulin in a mouse model of severe acute respiratory distress syndrome |pdf=|usr=}} | ||
{{tp|p=32380958|t=2020. Extracellular HMGB1: a therapeutic target in severe pulmonary inflammation including COVID-19?|pdf=|usr=}} | {{tp|p=32380958|t=2020. Extracellular HMGB1: a therapeutic target in severe pulmonary inflammation including COVID-19?|pdf=|usr=}} | ||
{{tp|p=32531537|t=2020. RAGE receptor: May be a potential inflammatory mediator for SARS-COV-2 infection?|pdf=|usr=009}} | {{tp|p=32531537|t=2020. RAGE receptor: May be a potential inflammatory mediator for SARS-COV-2 infection?|pdf=|usr=009}} | ||
| + | {{tp|p=32600307|t=2020. The alpha7 nicotinic acetylcholine receptor agonist, GTS-21, attenuates hyperoxia-induced acute inflammatory lung injury by alleviating the accumulation of HMGB1 in the airways and the circulation.|pdf=|usr=015}} | ||
| + | {{tp|p=32629817|t=2020. Influence of Herbal Medicines on HMGB1 Release, SARS-CoV-2 Viral Attachment, Acute Respiratory Failure, and Sepsis. A Literature Review.|pdf=|usr=012}} | ||
| + | {{tp|p=32723229|t=2020. Could Targeting HMGB1 be useful for the Clinical Management of COVID-19 Infection?|pdf=|usr=017}} | ||
| + | {{tp|p=33236418|t=2020. HMGB1: A pleiotropic activity.|pdf=|usr=021}} | ||
| + | {{tp|p=32760352|t=2020. COVID-19 and Diabetes: The Importance of Controlling RAGE.|pdf=|usr=018}} | ||
Aktuelle Version vom 12. April 2021, 15:47 Uhr
| PHA Biologicals |
ich habe seinerzeit den dewiki über hmgb1 erstmalig geschrieben https://de.wikipedia.org/w/index.php?title=High-Mobility-Group-Protein_B1&oldid=44046975 , aber wie man weiß, wikipedia kloppt die autoren tot und seit 2009 mache ich andere medizinische Webinhalte.
32375153 2020. HMGB1: A Possible Crucial Therapeutic Target for COVID-19?
23607598 2013. (x)Involvement of high mobility group box 1 and the therapeutic effect of recombinant thrombomodulin in a mouse model of severe acute respiratory distress syndrome
32380958 2020. Extracellular HMGB1: a therapeutic target in severe pulmonary inflammation including COVID-19?
32531537 2020. RAGE receptor: May be a potential inflammatory mediator for SARS-COV-2 infection?
32600307 2020. The alpha7 nicotinic acetylcholine receptor agonist, GTS-21, attenuates hyperoxia-induced acute inflammatory lung injury by alleviating the accumulation of HMGB1 in the airways and the circulation.
32629817 2020. Influence of Herbal Medicines on HMGB1 Release, SARS-CoV-2 Viral Attachment, Acute Respiratory Failure, and Sepsis. A Literature Review.
32723229 2020. Could Targeting HMGB1 be useful for the Clinical Management of COVID-19 Infection?
33236418 2020. HMGB1: A pleiotropic activity.
32760352 2020. COVID-19 and Diabetes: The Importance of Controlling RAGE.
